Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Tax Rate: 2019-2025

Historic Tax Rate for Catalyst Pharmaceuticals (CPRX) over the last 6 years, with Sep 2025 value amounting to 25.69%.

  • Catalyst Pharmaceuticals' Tax Rate rose 241.00% to 25.69% in Q3 2025 from the same period last year, while for Sep 2025 it was 24.05%, marking a year-over-year decrease of 660.00%. This contributed to the annual value of 24.45% for FY2024, which is 1256.00% down from last year.
  • According to the latest figures from Q3 2025, Catalyst Pharmaceuticals' Tax Rate is 25.69%, which was up 3.60% from 24.80% recorded in Q2 2025.
  • Catalyst Pharmaceuticals' Tax Rate's 5-year high stood at 50.82% during Q4 2023, with a 5-year trough of 12.53% in Q3 2022.
  • In the last 3 years, Catalyst Pharmaceuticals' Tax Rate had a median value of 23.29% in 2024 and averaged 25.38%.
  • As far as peak fluctuations go, Catalyst Pharmaceuticals' Tax Rate surged by 2,799bps in 2023, and later plummeted by 2,555bps in 2024.
  • Over the past 5 years, Catalyst Pharmaceuticals' Tax Rate (Quarterly) stood at 27.35% in 2021, then plummeted by 451bps to 22.83% in 2022, then skyrocketed by 2,799bps to 50.82% in 2023, then tumbled by 2,555bps to 25.27% in 2024, then surged by 241bps to 25.69% in 2025.
  • Its Tax Rate was 25.69% in Q3 2025, compared to 24.80% in Q2 2025 and 20.41% in Q1 2025.